Table 1.
The distribution of patients and the risk factors of mucormycosis in a five-year study period.
| 2010 | 2011 | 2012 | 2013 | 2014 | Total | |
|---|---|---|---|---|---|---|
| Number of cases reported | 28 | 14 | 9 | 17 | 14 | 82 |
| Male/Female | 22/6 | 7/7 | 7/2 | 12/5 | 7/7 | 55/27 |
| Age | ||||||
| <15 years | 1 | 1 | - | - | 1 | 3 |
| 15–30 years | 4 | 3 | 1 | 2 | - | 10 |
| 31–45 years | 11 | 4 | 2 | 7 | 4 | 28 |
| 46–60 years | 11 | 4 | 4 | 7 | 7 | 33 |
| >60 years | 1 | 2 | 2 | 1 | 2 | 8 |
| Risk Factors | ||||||
| Diabetes mellitus | 15 | 9 | 8 | 11 | 8 | 51 |
| Intramuscular injection | 4 | 2 | - | 3 | 3 | 12 |
| Iron therapy/dialysis | 2 | - | - | - | - | 2 |
| Others (malignancy, underlying infection, post- surgery, trauma, etc.) | 3 | 2 | 1 | - | 2 | 8 |
| None | 8 | 3 | - | 4 | 1 | 16 |
| Site of mucormycosis | ||||||
| Rhino-orbito-cerebral | 14 | 9 | 6 | 6 | 2 | 37 |
| Cutaneous | 8 | 4 | - | 6 | 7 | 25 |
| Pulmonary | 1 | 1 | 3 | 4 | 5 | 14 |
| Oral cavity | 3 | - | - | 1 | - | 4 |
| Gastrointestinal | 2 | - | - | - | - | 2 |